Trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a trial that will use stem cells from babies' own umbilical cords to treat heart defects such as hypoplastic left heart syndrome. The trial, considered the first of its kind, will commence upon enrollment of 10 eligible patients.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Rochester, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC